NOAEL Studies
Cosmetic Ingredient
Dimethyl Stearamine NOAEL Studies
INCI: DIMETHYL STEARAMINE
CAS: 124-28-7
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
CIR_vision_codex 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| CIR_vision_codex | NOAEL | =50 | mg/kg bw | rat | oral | 14 days | developmental toxicity | {"citation":"300; 3; 5","dose":"In the 300 mg/kg bw group, 3 of the 5 females died during the study while all of the males survived to the end of the study.","effect":"e group. In the 300 mg/kg bw group, 3 of the 5 females died during the study while all of the males survived to the end of the study. No other information is provided about effects observed in the highest dose group. Animals in the 150 mg/kg bw group were observed rubbing their snouts in the bedding material after dosing for approximately 5 minutes. This was not observed in the 50 mg/kg bw group. No mention is made regarding this behavior in the 300 mg/kg bw group. The authors concluded that 50 mg/kg bw is an oral NOEL based on this study.12 REPRODUCTIVE AND DEVELOPMENTAL EFFECTS Dimethyl Lauramine Sprague-Dawley rats (10/sex/group) were treated by gavage with dimethyl lauramine at dose levels of 0, 50, 150, 300 and 450 mg/kg bw/day.12 Males were treated 14 days prior to mating and during the 14-day mating period and females were treated 14 days prior to mating and throughout the mating, pregnancy and lactation periods. The highest dose group was discontinued due to the deaths of 3 animals (1 male and 2 females) on day 4 of the test and the poor health exhibited by the remaining a...","page":8,"pdf":"FR553.pdf","row_type":"noael_study","study_id":"FR553_noael_001"} |
| CIR_vision_codex | NOAEL | =50 | mg/kg bw | rat | oral | 14 days | developmental toxicity | {"citation":"300; 3; 5","dose":"In the 300 mg/kg bw group, 3 of the 5 females died during the study while all of the males survived to the end of the study.","effect":"e group. In the 300 mg/kg bw group, 3 of the 5 females died during the study while all of the males survived to the end of the study. No other information is provided about effects observed in the highest dose group. Animals in the 150 mg/kg bw group were observed rubbing their snouts in the bedding material after dosing for approximately 5 minutes. This was not observed in the 50 mg/kg bw group. No mention is made regarding this behavior in the 300 mg/kg bw group. The authors concluded that 50 mg/kg bw is an oral NOEL based on this study.12 REPRODUCTIVE AND DEVELOPMENTAL EFFECTS Dimethyl Lauramine Sprague-Dawley rats (10/sex/group) were treated by gavage with dimethyl lauramine at dose levels of 0, 50, 150, 300 and 450 mg/kg bw/day.12 Males were treated 14 days prior to mating and during the 14-day mating period and females were treated 14 days prior to mating and throughout the mating, pregnancy and lactation periods. The highest dose group was discontinued due to the deaths of 3 animals (1 male and 2 females) on day 4 of the test and the poor health exhibited by the remaining a...","page":8,"pdf":"FR553.pdf","row_type":"noael_study","study_id":"FR553_noael_001"} |
| CIR_vision_codex | NOAEL | =50 | mg/kg bw | rat | oral | 14 days | developmental toxicity | {"citation":"300; 3; 5","dose":"In the 300 mg/kg bw group, 3 of the 5 females died during the study while all of the males survived to the end of the study.","effect":"e group. In the 300 mg/kg bw group, 3 of the 5 females died during the study while all of the males survived to the end of the study. No other information is provided about effects observed in the highest dose group. Animals in the 150 mg/kg bw group were observed rubbing their snouts in the bedding material after dosing for approximately 5 minutes. This was not observed in the 50 mg/kg bw group. No mention is made regarding this behavior in the 300 mg/kg bw group. The authors concluded that 50 mg/kg bw is an oral NOEL based on this study.12 REPRODUCTIVE AND DEVELOPMENTAL EFFECTS Dimethyl Lauramine Sprague-Dawley rats (10/sex/group) were treated by gavage with dimethyl lauramine at dose levels of 0, 50, 150, 300 and 450 mg/kg bw/day.12 Males were treated 14 days prior to mating and during the 14-day mating period and females were treated 14 days prior to mating and throughout the mating, pregnancy and lactation periods. The highest dose group was discontinued due to the deaths of 3 animals (1 male and 2 females) on day 4 of the test and the poor health exhibited by the remaining a...","page":8,"pdf":"FR553.pdf","row_type":"noael_study","study_id":"FR553_noael_001"} |
| CIR_vision_codex | NOAEL | =50 | mg/kg bw | rat | oral | 14 days | developmental toxicity | {"citation":"300; 3; 5","dose":"In the 300 mg/kg bw group, 3 of the 5 females died during the study while all of the males survived to the end of the study.","effect":"e group. In the 300 mg/kg bw group, 3 of the 5 females died during the study while all of the males survived to the end of the study. No other information is provided about effects observed in the highest dose group. Animals in the 150 mg/kg bw group were observed rubbing their snouts in the bedding material after dosing for approximately 5 minutes. This was not observed in the 50 mg/kg bw group. No mention is made regarding this behavior in the 300 mg/kg bw group. The authors concluded that 50 mg/kg bw is an oral NOEL based on this study.12 REPRODUCTIVE AND DEVELOPMENTAL EFFECTS Dimethyl Lauramine Sprague-Dawley rats (10/sex/group) were treated by gavage with dimethyl lauramine at dose levels of 0, 50, 150, 300 and 450 mg/kg bw/day.12 Males were treated 14 days prior to mating and during the 14-day mating period and females were treated 14 days prior to mating and throughout the mating, pregnancy and lactation periods. The highest dose group was discontinued due to the deaths of 3 animals (1 male and 2 females) on day 4 of the test and the poor health exhibited by the remaining a...","page":8,"pdf":"FR553.pdf","row_type":"noael_study","study_id":"FR553_noael_001"} |
NTP_ICE_acute_oral 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| NTP_ICE_acute_oral | LD50 | =2116 | mg/kg bw | Rat | oral | acute | Rat Acute Oral Toxicity | OECD eChemPortal (undated); record_id=acute_oral_1912; row=7366; data_type=In Vivo; mixture=Chemical; chemical_name=N,N-Dimethyl-1-octadecanamine; preferred_name=N,N-Dimethyl-1-octadecanamine; dtxsid=DTXSID4027026; url=https://www.echemportal.org/echemportal/; url_comptox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID4027026; source_file=acute_oral.xlsx |
| NTP_ICE_acute_oral | LD50 | =2118 | mg/kg bw | Rat | oral | acute | Rat Acute Oral Toxicity | OECD eChemPortal (undated); record_id=acute_oral_1913; row=7365; data_type=In Vivo; mixture=Chemical; chemical_name=N,N-Dimethyl-1-octadecanamine; preferred_name=N,N-Dimethyl-1-octadecanamine; dtxsid=DTXSID4027026; url=https://www.echemportal.org/echemportal/; url_comptox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID4027026; source_file=acute_oral.xlsx |
ToxValDB_GESTIS_DNEL 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ToxValDB_GESTIS_DNEL | DNEL local | =1 | mg/m3 | Human | inhalation | - | Toxicity Value | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/6543dd69e4b045b9ff7cd87e; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://www.dguv.de/ifa/gestis/gestis-dnel-liste/index-2.jsp; STUDY_GROUP=GESTIS DNEL_dup_-_15631301_15631302:-:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_c0622856bedacfdba346968c1c8cf1ac |
openFDA substances 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 066975NG22 | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C20H43N","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"066975NG22"} |
| openFDA substances | FDA UNII substance identifier | 066975NG22 | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C20H43N","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"066975NG22"} |
| openFDA substances | FDA UNII substance identifier | 066975NG22 | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C20H43N","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"066975NG22"} |
| openFDA substances | FDA UNII substance identifier | 066975NG22 | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C20H43N","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"066975NG22"} |